OSI rejects hostile bid from Astellaspublished Mon, Mar 15 2010 21:00 GMT
OSI Pharmaceuticals yesterday rejected a $3.5bn, unsolicited takeover offer from Astellas Pharma, leaving its Japanese suitor in hostile pursuit of a US target for the...
Click for more articles from www.ft.com
|
|